http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4467096-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08 |
| filingDate | 1983-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768d7d73cc6d56c63d15336fc52e62fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ed4098cd45dd38a03d2fc505464d2b |
| publicationDate | 1984-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4467096-A |
| titleOfInvention | Isoxazolyl indolamines |
| abstract | This disclosure describes compounds of the formula <IMAGE> where R1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms or lower alkoxy having 1 to 4 carbon atoms, and R2 and R3 each independently represent lower alkyl as defined above, or R2 and R3 together with N represent <IMAGE> wherein n is 1, 2 or 3, and R4 and R5 each independently represent hydrogen or lower alkyl as defined above, or a pharmaceutically acceptable acid addition salt thereof, which are useful as anti-diabetic agents in particular as hypoglycemic agents and inhibiting or impeding post-prandial hyperglycemia. |
| priorityDate | 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.